Press Releases April 30, 2026 06:48 PM

NOVONIX Divests Non-Core Business to Focus on Synthetic Graphite

NOVONIX completes divestiture of non-core battery technology business to focus on synthetic graphite supply chain

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
NVX

NOVONIX Limited has finalized the sale of its NOVONIX Battery Technology Solutions Inc. business in Canada to its former CEO. This divestiture aligns with NOVONIX's strategic focus on building a vertically integrated synthetic graphite supply chain in North America to support domestic battery industry growth. The transaction involved a $1 sale price and NOVONIX retaining a 15% equity stake in the cathode materials business, Dryve Battery Materials Inc. The move aims to better allocate capital and management resources towards critical mineral supply for the battery and clean energy sector.

NOVONIX Divests Non-Core Business to Focus on Synthetic Graphite
NVX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • NOVONIX sold its Battery Technology Solutions division to its former CEO, marking a strategic divestiture of non-core assets.
  • The company is concentrating efforts on developing a vertically integrated synthetic graphite supply chain domestically in North America.
  • NOVONIX retains a 15% equity stake in Dryve Battery Materials, focused on innovative lithium-ion cathode technology commercialization.
  • The transaction supports the company's goal to enhance U.S. energy independence and battery materials supply chain resilience, positively impacting the battery manufacturing and clean energy sectors.

CHATTANOOGA, Tenn., April 30, 2026 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or the “Company”), a leading battery materials company, today announced that it has finalized and closed the previously announced sale of its NOVONIX Battery Technology Solutions Inc. (“BTS”) business in Nova Scotia, Canada, to its former Chief Executive Officer, Dr. Chris Burns (“Buyer”).

“The divestiture of the BTS division reflects our disciplined strategy of building a vertically integrated synthetic graphite supply chain in North America,” said Mike O’Kronley, CEO of NOVONIX. “By divesting non-core business segments, we are directing our management attention and capital toward advancing domestic supply of this critical mineral and supporting the growth of the North American battery industry.”

Founded in 2013 by Dr. Chris Burns and acquired by NOVONIX in 2017, BTS will now operate as two independent companies: Avrion Battery Labs Inc., which will provide advanced battery testing systems and specialized R&D services, and Dryve Battery Materials Inc., which will continue efforts to commercialize the patented pCAM-free dry synthesis platform for lithium-ion cathode materials.

Key Deal Terms: 

  • Share equity sale of the BTS business including all associated liabilities and assets
  • Transaction price of US $1.00
  • NOVONIX to receive a 15% equity stake in the cathode business, which will operate under Dryve Battery Materials Inc.
  • Cash balance at BTS as of Close is to be US$2M, subject to agreed adjustments
  • NOVONIX will provide certain transition services and will grant Buyer a trademark license through 31 December 2026

The transaction has now been successfully completed following the execution of definitive agreements and satisfaction of all closing conditions.

This announcement has been authorized for release by NOVONIX Chairman,  
Mr. Ron Edmonds.

About NOVONIX
NOVONIX strives to reduce supply chain risk, support U.S. energy independence, and establish a resilient battery materials supply chain. The company is building a North American platform for critical battery materials—anchored by its Chattanooga, Tennessee headquarters and anode materials operations, expanding through its patented all-dry, precursor-free cathode synthesis technology, and supported by industry-leading battery cell testing and R&D services.

Together, these capabilities position NOVONIX as an integrated supplier of advanced battery materials and technologies powering the energy storage and electrification economy.

To learn more, visit us at www.novonixgroup.com or on LinkedIn and X.

NOVONIX Limited
Investors: ir@novonixgroup.com
Media: media@novonixgroup.com

Dryve Battery Materials Inc.
media@dryvematerials.com

Avrion Battery Labs
media@avrionlabs.com

Cautionary Note Regarding Forward-Looking Statements

This communication contains forward-looking statements about the Company and the industry in which it operates. Forward-looking statements can generally be identified by use of words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would,” or other similar expressions. Examples of forward-looking statements in this communication include, among others, statements made regarding the anticipated benefit or impact of the BTS transaction, the advancement of the domestic supply of synthetic graphite, the growth of the North American battery industry, the future commercialization of cathode technology, and efforts to help localize the battery supply chain for critical materials and play a leading role in the transition to cleaner energy solutions.

The Company has based such statements on current expectations and projections about future events and trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. Such forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors which may cause actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include, among others, the timely deployment and scaling of its furnace technology, ability to meet the technical specifications and demand of existing and future customers, the accuracy of estimates regarding market size, expenses, future revenue, capital requirements, needs and access for additional financing, the availability and impact and compliance with the applicable terms of government funding and other support, ability to obtain patent rights effective to protect its technologies and processes and successfully defend any challenges to such rights and prevent others from commercializing such technologies and processes, and regulatory and economic developments in the United States, Australia, and other jurisdictions. These and other factors that could affect its business and results are included in its filings with the U.S. Securities and Exchange Commission (“SEC”), including the Company’s most recent annual report on Form 20-F. Copies of these filings may be obtained by visiting the Company’s Investor Relations website at www.novonixgroup.com or the SEC’s website at www.sec.gov.

Forward-looking statements are not guarantees of future performance or outcomes, and actual performance and outcomes may differ materially from those made in or suggested by the forward-looking statements contained in this communication. Accordingly, you should not place undue reliance on forward-looking statements. Any forward-looking statement in this communication is based only on information currently available to us and speaks only as of the date on which it is made. The Company undertakes no obligation to update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise, except as required by law.


Risks

  • The success of NOVONIX's strategy depends on the timely deployment and scaling of its furnace technology for synthetic graphite production, which carries execution risk.
  • Market demand and acceptance of Dryve Battery Materials' patented pCAM-free cathode technology may impact revenue growth and profitability.
  • Regulatory and economic uncertainties in the U.S., Canada, and Australia, including compliance with government funding conditions, could affect business operations and financial performance.

More from Press Releases

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Jun 14, 2026 Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026) Jun 14, 2026 Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026